Screening of tuberculosis by interferon-gamma assay before biologic therapy for rheumatoid arthritis
- PMID: 19211305
- DOI: 10.1016/j.tube.2008.12.004
Screening of tuberculosis by interferon-gamma assay before biologic therapy for rheumatoid arthritis
Abstract
Infection with Mycobacterium tuberculosis (M. tuberculosis) is a critical complication in anti-TNF therapies. In 141 BCG vaccinated healthy individuals and 71 rheumatoid arthritis (RA) patients as screening before anti-TNF therapies, M. tuberculosis specific immune responses were evaluated by tuberculin skin test (TST) and enzyme-linked immunospot assay (ELISPOT), which detected antigen specific IFN-gamma secreting cells in peripheral blood mononuclear cells simulated with either purified protein derivative (PPD), early secretory antigen target 6 (ESAT-6) or culture filtrate protein 10 (CFP-10). Induration over 5 mm in TST was found in 87.9% of controls and 21.4% of RA patients. Erythema size in TST was significantly suppressed in RA patients, especially those receiving prednisolone (PSL), whereas the PPD specific IFN-gamma secretion was less attenuated. Significant responses to either ESAT-6 or CFP-10 in ELISPOT were detected in 14.1% of RA patients including those having positive TST, while the ELISPOT assay was negative in all healthy individuals and 73.3% of RA patients having positive TST. Of ELISPOT positive RA patients, mean dosage of PSL was 4.58 mg and 1.25 mg in TST negative and positive patients, respectively. Thus, ELISPOT is useful for screening of tuberculosis in RA patients, even in those receiving corticosteroids.
Similar articles
-
Positive conversion of tuberculin skin test and performance of interferon release assay to detect hidden tuberculosis infection during anti-tumor necrosis factor agent trial.J Rheumatol. 2009 Oct;36(10):2158-63. doi: 10.3899/jrheum.090150. Epub 2009 Sep 1. J Rheumatol. 2009. PMID: 19723901
-
Usefulness of enzyme-linked immunospot assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment.J Rheumatol. 2008 Jul;35(7):1271-6. Epub 2008 Mar 15. J Rheumatol. 2008. PMID: 18381793
-
Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population.J Rheumatol. 2008 May;35(5):776-81. Epub 2008 Apr 1. J Rheumatol. 2008. PMID: 18398944 Clinical Trial.
-
[Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].Kekkaku. 2006 Nov;81(11):681-6. Kekkaku. 2006. PMID: 17154047 Review. Japanese.
-
[Evolution of IGRA researches].Kekkaku. 2008 Sep;83(9):641-52. Kekkaku. 2008. PMID: 18979999 Review. Japanese.
Cited by
-
Tuberculin skin test repetition after TNF-α inhibitors in patients with chronic inflammatory arthritis: a long-term retrospective cohort in endemic area.Adv Rheumatol. 2024 Sep 13;64(1):70. doi: 10.1186/s42358-024-00406-7. Adv Rheumatol. 2024. PMID: 39272122
-
A case of preventable pulmonary tuberculosis in a Greenlandic, heavily immune suppressed patient.Respir Med Case Rep. 2012;5:62-4. doi: 10.1016/j.rmedc.2011.08.006. Epub 2011 Oct 5. Respir Med Case Rep. 2012. PMID: 26057468 Free PMC article.
-
Preliminary Studies of the Immunomodulator Effect of the Bougainvillea xbuttiana Extract in a Mouse Model.Evid Based Complement Alternat Med. 2015;2015:479412. doi: 10.1155/2015/479412. Epub 2015 Mar 16. Evid Based Complement Alternat Med. 2015. PMID: 25861362 Free PMC article.
-
[Clinical presentation of tuberculosis in routine practice].Z Rheumatol. 2012 Oct;71(8):711-6. doi: 10.1007/s00393-012-0991-y. Z Rheumatol. 2012. PMID: 22815006 German.
-
Interferon-gamma release assays in the detection of latent tuberculosis infection in patients with inflammatory arthritis scheduled for anti-tumour necrosis factor treatment.Clin Rheumatol. 2012 May;31(5):785-94. doi: 10.1007/s10067-012-1938-z. Epub 2012 Jan 21. Clin Rheumatol. 2012. PMID: 22271230
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous